Viatris (VTRS) Acquisitions (2020 - 2024)
Viatris (VTRS) posted Acquisitions of $350.0 million for Q1 2024, down 47.58% on a QoQ basis from $667.7 million in Q1 2023, and down 47.58% year-over-year from $667.7 million in Q2 2023.
Analysis
Viatris (VTRS) Acquisitions (2020 - 2024) Analysis & Trends
Viatris has reported Acquisitions for 4 years, with the latest figure at $350.0 million in Q1 2024.
- On a quarterly basis, Acquisitions fell 47.58% year-over-year to $350.0 million in Q1 2024; TTM through Dec 2024 was $350.0 million, a 47.58% decrease from a year earlier, with the FY2024 full-year figure at $350.0 million, down 47.58% from the prior year.
- Acquisitions was $350.0 million for Q1 2024 at Viatris, down from $667.7 million in the prior quarter.
- The five-year high for Acquisitions was $667.7 million in Q1 2023, with the low at -$415.8 million in Q4 2020.
- Average Acquisitions over 4 years is $81.2 million, with a median of $36.5 million recorded in 2021.
- The largest YoY upside for Acquisitions was 47.58% in 2024 against a maximum downside of 47.58% in 2024.
- Over 4 years, Acquisitions stood at -$415.8 million in 2020, then soared by 33.38% to -$277.0 million in 2021, then surged by 341.05% to $667.7 million in 2023, then slumped by 47.58% to $350.0 million in 2024.
- The last three Acquisitions figures came in at $350.0 million (Q1 2024), $667.7 million (Q1 2023), and -$277.0 million (Q1 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -2.32 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 350.00 Mn |
| Mar 31, 2023 | 667.70 Mn |
| Mar 31, 2021 | -277.00 Mn |
| Dec 31, 2020 | -415.80 Mn |